We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
-7.09%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
(-95%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-1,882.29%
Top 10 Holdings %
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACV Auctions
ACVA
|
+$194K |
| 2 |
Rapid7
RPD
|
+$183K |
| 3 |
EFC
Ellington Financial
EFC
|
+$181K |
| 4 |
Banco Santander
SAN
|
+$159K |
| 5 |
Oscar Health
OSCR
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXL Service
EXLS
|
+$830K |
| 2 |
Delek US
DK
|
+$724K |
| 3 |
Broadcom
AVGO
|
+$669K |
| 4 |
Itron
ITRI
|
+$666K |
| 5 |
Brinker International
EAT
|
+$649K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.83% |
| 2 | Technology | 15.87% |
| 3 | Healthcare | 10.98% |
| 4 | Industrials | 10.86% |
| 5 | Real Estate | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Healthcare Realty
HR
$7.36B
| – | – |
-11,818
| Closed | -$200K |
|
352
Herc Holdings
HRI
$4.94B
| – | – |
-1,524
| Closed | -$226K |
|
353
Hercules Capital
HTGC
$3.01B
| – | – |
-11,918
| Closed | -$224K |
|
354
Heartland Express
HTLD
$1.17B
| – | – |
-40,960
| Closed | -$370K |
|
355
Hertz
HTZ
$584M
| – | – |
-104,972
| Closed | -$540K |
|
356
IBEX
IBEX
$470M
| – | – |
-7,716
| Closed | -$295K |
|
357
ICICI Bank
IBN
$108B
| – | – |
-9,246
| Closed | -$276K |
|
358
ICL Group
ICL
$6.78B
| – | – |
-48,594
| Closed | -$277K |
|
359
IDT Corp
IDT
$1.57B
| – | – |
-4,166
| Closed | -$213K |
|
360
Idexx Laboratories
IDXX
$44.5B
| – | – |
-463
| Closed | -$313K |
|
361
Intercorp Financial Services
IFS
$6.61B
| – | – |
-8,245
| Closed | -$349K |
|
362
IHS Holding
IHS
$2.75B
| – | – |
-29,817
| Closed | -$222K |
|
363
IMAX
IMAX
$2.12B
| – | – |
-12,510
| Closed | -$462K |
|
364
First Internet Bancorp
INBK
$236M
| – | – |
-10,680
| Closed | -$223K |
|
365
InfuSystem Holdings
INFU
$180M
| – | – |
-46,916
| Closed | -$421K |
|
366
Inogen
INGN
$173M
| – | – |
-55,240
| Closed | -$371K |
|
367
Inspire Medical Systems
INSP
$1.53B
| – | – |
-4,358
| Closed | -$402K |
|
368
Intel
INTC
$530B
| – | – |
-7,355
| Closed | -$271K |
|
369
Invitation Homes
INVH
$17.9B
| – | – |
-14,403
| Closed | -$400K |
|
370
Ionis Pharmaceuticals
IONS
$8.75B
| – | – |
-2,661
| Closed | -$211K |
|
371
Innospec
IOSP
$2.07B
| – | – |
-2,817
| Closed | -$216K |
|
372
Samsara
IOT
$21B
| – | – |
-11,399
| Closed | -$404K |
|
373
Iridium Communications
IRDM
$5.01B
| – | – |
-21,298
| Closed | -$370K |
|
374
iRhythm Holdings
IRTC
$3.58B
| – | – |
-1,292
| Closed | -$229K |
|
375
Innovative Solutions & Support
ISSC
$332M
| – | – |
-17,274
| Closed | -$327K |
|
Similar funds
WA
BS
RG
MP
AIA
CCM
DFA
T
PharVision Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.
- PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
- PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
- PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
- PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
- PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
- PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
- PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.